Company intelligence / Profile preview

theBlue.ai

Hamburg, Hamburg, Germanytheblue.ai ↗

Ownership: Private
Development stage: Other

Overview

theBlue.ai develops custom artificial intelligence solutions with significant activity in healthcare, including secure medical image/data handling, generative AI assistants, and process automation. Their ShareMedix platform enables secure de-identification of sensitive health data such as DICOM images to facilitate compliant sharing between institutions[3][5]. They also support digital transformation projects across industries with expertise spanning computer vision, NLP, predictive analytics, cloud/edge deployment, and user-focused app development[2].

Modalities: Medical ImagingHealthcare Data Processing
Industry: Biomedical IT and Biomedical Data Platforms

Partnerships

apoQlar (virtual assistant/document management)[1]Policy‑Insider.AI/RPP Group (AI-powered transparency tools)[1]

Beyond the preview

Go deeper on theBlue.ai.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on theBlue.ai.

Explore the full profile